178 related articles for article (PubMed ID: 36635290)
1. ST8SIA6-AS1 contributes to hepatocellular carcinoma progression by targeting miR-142-3p/HMGA1 axis.
Feng T; Yao Y; Luo L; Zou H; Xiang G; Wei L; Yang Q; Shi Y; Huang X; Lai C
Sci Rep; 2023 Jan; 13(1):650. PubMed ID: 36635290
[TBL] [Abstract][Full Text] [Related]
2. ST8SIA6-AS1 promotes the development of hepatocellular carcinoma cells through miR-338-3p/NONO Axis.
Kuai J; Zheng L; Yi X; Liu Z; Qiu B; Lu Z; Jiang Y
Dig Liver Dis; 2021 Sep; 53(9):1192-1200. PubMed ID: 33722502
[TBL] [Abstract][Full Text] [Related]
3. ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6.
Li Y; Jiang A
Cancer Biol Ther; 2020 Jul; 21(7):647-655. PubMed ID: 32420798
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ST8SIA6-AS1 facilitates hepatocellular carcinoma progression by governing miR-651-5p/TM4SF4 axis.
Mou Y; Ding X
Anticancer Drugs; 2022 Sep; 33(8):741-751. PubMed ID: 35946523
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression.
Zhang X; Xu S; Hu C; Fang K; Zhou J; Guo Z; Zhu G; Li L
Biochem Biophys Res Commun; 2020 Dec; 533(4):1039-1047. PubMed ID: 33012505
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
Qiao Y; Wang B; Yan Y; Niu L
Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
[TBL] [Abstract][Full Text] [Related]
7. LncRNA F11-AS1 suppresses liver hepatocellular carcinoma progression by competitively binding with miR-3146 to regulate PTEN expression.
Du J; Chen M; Liu J; Hu P; Guan H; Jiao X
J Cell Biochem; 2019 Oct; 120(10):18457-18464. PubMed ID: 31168823
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ST8SIA6-AS1 promotes colorectal cancer cell proliferation, migration and invasion by regulating the miR-5195/PCBP2 axis.
Huang CM; Cao GY; Yang CX; Chen Y; Liu GD; Xu BW; Zhang X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4203-4211. PubMed ID: 32373956
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1).
Mou Y; Sun Q
Bioengineered; 2022 Jan; 13(1):746-758. PubMed ID: 34859735
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA CERS6-AS1 Accelerates the Proliferation and Migration of Pancreatic Cancer Cells by Sequestering MicroRNA-15a-5p and MicroRNA-6838-5p and Modulating HMGA1.
Shen R; Wang X; Wang S; Zhu D; Li M
Pancreas; 2021 Apr; 50(4):617-624. PubMed ID: 33939677
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
13. LncRNA BBOX1-AS1 Contributes to the Progression of Esophageal Carcinoma by Targeting the miR-361-3p/COL5A1 Axis.
Lu YH; He DS; Li Y; Wang H; Ma RD
Biochem Genet; 2023 Aug; 61(4):1351-1368. PubMed ID: 36586008
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TTN-AS1 acts as a tumor promoter in gallbladder carcinoma by regulating miR-107/HMGA1 axis.
Lin Z; Li Y; Shao R; Hu Y; Gao H
World J Surg Oncol; 2021 Jun; 19(1):163. PubMed ID: 34090483
[TBL] [Abstract][Full Text] [Related]
15. RNF144A-AS1 promotes the development of glioma cells by targeting miR-665/HMGA1 axis.
Tong X; Yang Z; Wang Q; Zhang D
Neurosci Lett; 2021 Nov; 765():136259. PubMed ID: 34560189
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
[TBL] [Abstract][Full Text] [Related]
17. lncRNA ST8SIA6-AS1 facilitates proliferation and invasion in liver cancer by regulating miR-142-3p.
Zhang Y; Yang Y; Zhang Y; Liu Z
Exp Ther Med; 2021 Dec; 22(6):1348. PubMed ID: 34659494
[TBL] [Abstract][Full Text] [Related]
18. Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma.
Han W; Yu G; Meng X; Hong H; Zheng L; Wu X; Zhang D; Yan B; Ma Y; Li X; Wang Q
Mol Cell Biochem; 2019 Oct; 460(1-2):37-51. PubMed ID: 31222560
[TBL] [Abstract][Full Text] [Related]
19. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
[TBL] [Abstract][Full Text] [Related]
20. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis.
Zhang L; Zhao Y; Guan H; Zhang D
Cancer Biomark; 2022; 34(3):443-457. PubMed ID: 35275521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]